On the Record · QuidelOrtho
QuidelOrtho competitors, on the record
The companies QuidelOrtho names as competitors in its annual reports, 2023 to 2025, and the companies that name QuidelOrtho, each with the sentence and the filing.
Who QuidelOrtho names
| Company | Named in |
|---|---|
| Abbott Laboratories | 2025 |
| Bio-Rad | 2025 |
| bioMérieux | 2025 |
| Danaher | 2025 |
| Diasorin | 2025 |
| Hologic | 2025 |
| Qiagen | 2025 |
| Revvity | 2025 |
| Roche | 2025 |
| Siemens Healthineers | 2025 |
| Thermo Fisher Scientific | 2025 |
| Waters Corporation | 2025 |
| Wermerson Immuncor | 2025 |
In its own words
Abbott Laboratories, Bio-Rad, bioMérieux, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation, Wermerson Immuncor
Word for word“Some of our principal competitors include, among others, Abbott Laboratories, bioMérieux, Bio-Rad, Danaher, Diasorin, Hologic, Qiagen, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Waters Corporation (acquired BD Diagnostics division) and Wermerson Immuncor.” 10-K for 2025
Who names QuidelOrtho
Companies whose own annual reports name QuidelOrtho as a competitor.
Word for word“Major competitors for our products in the Clinical Diagnostics segment include Abbott Laboratories, Becton Dickinson, bioMérieux, Danaher, DiaSorin, Werfen, QuidelOrtho, Roche, Siemens Healthineers, Thermo Fisher Scientific and Tosoh.” 10-K for 2025
Read from QuidelOrtho’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-19. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.